Minimum inhibitory concentration (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Minimum inhibitory concentration" in English language version.

refsWebsite

Global rank English rank

19nih.gov

4^th place

13doi.org

2^nd place

7worldcat.org

5^th place

3semanticscholar.org

11^th place

8^th place

1zenodo.org

621^st place

380^th place

1eucast.org

low place

1biomerieux-usa.com

low place

1books.google.com

3^rd place

biomerieux-usa.com

"ETEST". bioMérieux. Retrieved 2019-04-23.

books.google.com

Tripathi KD (2013). Essentials of Medical Pharmacology (7th ed.). New Delhi, India: Jaypee Brothers Medical Publishers. pp. 696, 697. ISBN 9789350259375.

doi.org

Magréault S, Jauréguy F, Carbonnelle E, Zahar JR (December 2010). "When and How to Use MIC in Clinical Practice?". Antibiotics. 11 (12): Article 1748. doi:10.3390/antibiotics11121748. PMC 9774413. PMID 36551405.
Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D (December 2010). "Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods". Drug Resistance Updates. 13 (6): 180–195. doi:10.1016/j.drup.2010.09.002. PMID 21050800.
Cushnie TP, Cushnie B, Echeverría J, Fowsantear W, Thammawat S, Dodgson JL, Law S, Clow SM (June 2020). "Bioprospecting for antibacterial drugs: a multidisciplinary perspective on natural product source material, bioassay selection and avoidable pitfalls". Pharmaceutical Research. 37 (7): Article 125. doi:10.1007/s11095-020-02849-1. PMID 32529587. S2CID 254932190.
McKinnon PS, Davis SL (April 2004). "Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases". European Journal of Clinical Microbiology & Infectious Diseases. 23 (4): 271–88. doi:10.1007/s10096-004-1107-7. PMID 15015030. S2CID 28455936.
Humphries R, Bobenchik AM, Hindler JA, Schuetz AN (November 2021). "Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition". J Clin Microbiol. 59 (12): Article e0021321. doi:10.1128/JCM.00213-21. PMC 8601225. PMID 34550809.
Andrews JM (July 2001). "Determination of minimum inhibitory concentrations". The Journal of Antimicrobial Chemotherapy. 48 Suppl 1 (suppl 1): 5–16. doi:10.1093/jac/48.suppl_1.5. PMID 11420333.
O'Neill AJ, Chopra I (August 2004). "Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques". Expert Opinion on Investigational Drugs. 13 (8): 1045–63. doi:10.1517/13543784.13.8.1045. PMID 15268641. S2CID 24016698.
Wheat PF (July 2001). "History and development of antimicrobial susceptibility testing methodology". The Journal of Antimicrobial Chemotherapy. 48 Suppl 1 (suppl_1): 1–4. doi:10.1093/jac/48.suppl_1.1. PMID 11420332.
Diene SM, Abat C, Rolain JM, Raoult D (July 2017). "How artificial is the antibiotic resistance definition?". The Lancet Infectious Diseases. 17 (7): 690. doi:10.1016/S1473-3099(17)30338-9. PMID 28653629.
Cameron DR, Howden BP, Peleg AY (September 2011). "The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes". Clinical Infectious Diseases. 53 (6): 576–82. doi:10.1093/cid/cir473. PMID 21865195.
Geisinger E, Isberg RR (February 2017). "Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria". The Journal of Infectious Diseases. 215 (suppl_1): S9 – S17. doi:10.1093/infdis/jiw402. PMC 5853982. PMID 28375515.
Gullberg E, Cao S, Berg OG, Ilbäck C, Sandegren L, Hughes D, Andersson DI (July 2011). "Selection of resistant bacteria at very low antibiotic concentrations". PLOS Pathogens. 7 (7): e1002158. doi:10.1371/journal.ppat.1002158. PMC 3141051. PMID 21811410.
Guengerich FP (2011). "Mechanisms of drug toxicity and relevance to pharmaceutical development". Drug Metabolism and Pharmacokinetics. 26 (1): 3–14. doi:10.2133/dmpk.DMPK-10-RV-062. PMC 4707670. PMID 20978361.

eucast.org

"New definitions of S, I and R from 2019". European Committee on Antimicrobial Susceptibility Testing (EUCAST). Retrieved 5 May 2023.

nih.gov

pubmed.ncbi.nlm.nih.gov

Magréault S, Jauréguy F, Carbonnelle E, Zahar JR (December 2010). "When and How to Use MIC in Clinical Practice?". Antibiotics. 11 (12): Article 1748. doi:10.3390/antibiotics11121748. PMC 9774413. PMID 36551405.
Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D (December 2010). "Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods". Drug Resistance Updates. 13 (6): 180–195. doi:10.1016/j.drup.2010.09.002. PMID 21050800.
Bennani FE, Doudach L, El Rhayam Y, Karrouchi K, Cherrah Y, Tarib A, Ansar M, Faouzi ME (November 2022). "Identification of the new progress on pyrazole derivatives molecules as antimicrobial and antifungal agents". West African Journal of Medicine. 39 (11): 1217–1244. PMID 36455285.
Cushnie TP, Cushnie B, Echeverría J, Fowsantear W, Thammawat S, Dodgson JL, Law S, Clow SM (June 2020). "Bioprospecting for antibacterial drugs: a multidisciplinary perspective on natural product source material, bioassay selection and avoidable pitfalls". Pharmaceutical Research. 37 (7): Article 125. doi:10.1007/s11095-020-02849-1. PMID 32529587. S2CID 254932190.
McKinnon PS, Davis SL (April 2004). "Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases". European Journal of Clinical Microbiology & Infectious Diseases. 23 (4): 271–88. doi:10.1007/s10096-004-1107-7. PMID 15015030. S2CID 28455936.
Humphries R, Bobenchik AM, Hindler JA, Schuetz AN (November 2021). "Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition". J Clin Microbiol. 59 (12): Article e0021321. doi:10.1128/JCM.00213-21. PMC 8601225. PMID 34550809.
Andrews JM (July 2001). "Determination of minimum inhibitory concentrations". The Journal of Antimicrobial Chemotherapy. 48 Suppl 1 (suppl 1): 5–16. doi:10.1093/jac/48.suppl_1.5. PMID 11420333.
O'Neill AJ, Chopra I (August 2004). "Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques". Expert Opinion on Investigational Drugs. 13 (8): 1045–63. doi:10.1517/13543784.13.8.1045. PMID 15268641. S2CID 24016698.
Wheat PF (July 2001). "History and development of antimicrobial susceptibility testing methodology". The Journal of Antimicrobial Chemotherapy. 48 Suppl 1 (suppl_1): 1–4. doi:10.1093/jac/48.suppl_1.1. PMID 11420332.
Diene SM, Abat C, Rolain JM, Raoult D (July 2017). "How artificial is the antibiotic resistance definition?". The Lancet Infectious Diseases. 17 (7): 690. doi:10.1016/S1473-3099(17)30338-9. PMID 28653629.
Cameron DR, Howden BP, Peleg AY (September 2011). "The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes". Clinical Infectious Diseases. 53 (6): 576–82. doi:10.1093/cid/cir473. PMID 21865195.
Geisinger E, Isberg RR (February 2017). "Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria". The Journal of Infectious Diseases. 215 (suppl_1): S9 – S17. doi:10.1093/infdis/jiw402. PMC 5853982. PMID 28375515.
Gullberg E, Cao S, Berg OG, Ilbäck C, Sandegren L, Hughes D, Andersson DI (July 2011). "Selection of resistant bacteria at very low antibiotic concentrations". PLOS Pathogens. 7 (7): e1002158. doi:10.1371/journal.ppat.1002158. PMC 3141051. PMID 21811410.
Guengerich FP (2011). "Mechanisms of drug toxicity and relevance to pharmaceutical development". Drug Metabolism and Pharmacokinetics. 26 (1): 3–14. doi:10.2133/dmpk.DMPK-10-RV-062. PMC 4707670. PMID 20978361.

ncbi.nlm.nih.gov

Magréault S, Jauréguy F, Carbonnelle E, Zahar JR (December 2010). "When and How to Use MIC in Clinical Practice?". Antibiotics. 11 (12): Article 1748. doi:10.3390/antibiotics11121748. PMC 9774413. PMID 36551405.
Humphries R, Bobenchik AM, Hindler JA, Schuetz AN (November 2021). "Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition". J Clin Microbiol. 59 (12): Article e0021321. doi:10.1128/JCM.00213-21. PMC 8601225. PMID 34550809.
Geisinger E, Isberg RR (February 2017). "Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria". The Journal of Infectious Diseases. 215 (suppl_1): S9 – S17. doi:10.1093/infdis/jiw402. PMC 5853982. PMID 28375515.
Gullberg E, Cao S, Berg OG, Ilbäck C, Sandegren L, Hughes D, Andersson DI (July 2011). "Selection of resistant bacteria at very low antibiotic concentrations". PLOS Pathogens. 7 (7): e1002158. doi:10.1371/journal.ppat.1002158. PMC 3141051. PMID 21811410.
Guengerich FP (2011). "Mechanisms of drug toxicity and relevance to pharmaceutical development". Drug Metabolism and Pharmacokinetics. 26 (1): 3–14. doi:10.2133/dmpk.DMPK-10-RV-062. PMC 4707670. PMID 20978361.

semanticscholar.org

api.semanticscholar.org

Cushnie TP, Cushnie B, Echeverría J, Fowsantear W, Thammawat S, Dodgson JL, Law S, Clow SM (June 2020). "Bioprospecting for antibacterial drugs: a multidisciplinary perspective on natural product source material, bioassay selection and avoidable pitfalls". Pharmaceutical Research. 37 (7): Article 125. doi:10.1007/s11095-020-02849-1. PMID 32529587. S2CID 254932190.
McKinnon PS, Davis SL (April 2004). "Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases". European Journal of Clinical Microbiology & Infectious Diseases. 23 (4): 271–88. doi:10.1007/s10096-004-1107-7. PMID 15015030. S2CID 28455936.
O'Neill AJ, Chopra I (August 2004). "Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques". Expert Opinion on Investigational Drugs. 13 (8): 1045–63. doi:10.1517/13543784.13.8.1045. PMID 15268641. S2CID 24016698.

worldcat.org

search.worldcat.org

Fleming A (1944). On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. H. K. Lewis & Co. Ltd. OCLC 25424051.
Cockerill FR (2012). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard (9th ed.). Wayne, Pa: Clinical and Laboratory Standards Institute. ISBN 978-1562387846. OCLC 1016466655.
Cockerill F (2012). Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute. ISBN 978-1562387853. OCLC 795927370.
Schwalbe R, Steele-Moore L, Goodwin AC (2007). Antimicrobial susceptibility testing protocols. Boca Raton: CRC Press. ISBN 9781420014495. OCLC 666899344.
World Health Organization (2015-12-15). Global antimicrobial resistance surveillance system: manual for early implementation. World Health Organization. Geneva, Switzerland. ISBN 978-9241549400. OCLC 950637154.{{cite book}}: CS1 maint: location missing publisher (link)
Cockerill F (2015). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard (Tenth ed.). Wayne, Pa.: Clinical and Laboratory Standards Institute. ISBN 978-1562387839. OCLC 932608948.
Gallagher JC (2016-11-21). Antibiotics simplified. Jones & Bartlett Publishers. ISBN 9781284111293. OCLC 952657550.

zenodo.org

Cushnie TP, Cushnie B, Echeverría J, Fowsantear W, Thammawat S, Dodgson JL, Law S, Clow SM (June 2020). "Bioprospecting for antibacterial drugs: a multidisciplinary perspective on natural product source material, bioassay selection and avoidable pitfalls". Pharmaceutical Research. 37 (7): Article 125. doi:10.1007/s11095-020-02849-1. PMID 32529587. S2CID 254932190.